Physician
Ophthalmology
Dr. David J. Izbrand is an expert in the field of Ophthalmology. He went to University of Texas Medical School. He received awards:"Meaningful Use Stage 1 Certification", "Fellow (FAAO)" and "Fellow (FACS)". David J. Izbrand, MD is a published doctor. He published 2 publications, including: 'Airway obstruction and pulmonary edema.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
Schools
University of Texas At Houston Medical School At Houston
John Peter Smith Hospital
Parkland Meml Hospital Sw Med School
Procedures Preformed
- Blepharoplasty
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Eyelid Surgery
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Aphakia and Other Disorders of Lens
- Benign Neoplasm of Choroid
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- American Republic
- Blue Card PPO
- Blue Choice
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- HealthSmart
- Choice Care PPO
- Medicare MCR
- PHCS Network PPO
- National Elevator
- Old Surety Life Insurance CompanyMedicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- USI Affinity
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FAAO)
- Fellow (FACS)
Education
-
John Peter Smith Hospital
-
University of Texas Medical School
Drug Facts
NPI NUMBER |
|
1639145410 |
NPPES Provider LastName |
|
IZBRAND |
NPPES Provider FirstName |
|
DAVID |
NPPES Provider ZIPCode |
|
796013044 |
NPPES Provider State |
|
TX |
Specialty Description |
|
Ophthalmology |
Total Claim Count |
|
1327.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1639145410 |
Last Name Of The Provider |
IZBRAND |
First Name Of The Provider |
DAVID |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog